Our Product / Services
Our Complete range of products are Rhogam Injection, Anti Rabies Vaccine, Oral Polio Vaccine, QUADRI MENINGO VACCINE and Cervarix Vaccine.
Owing to our state-of-the-art warehouse, we efficiently entertain both automated inbound and outbound consignments with utmost proficiency. The products are sorted and segregated to make sure that the delivery commences systematically. We abide by the strict delivery policies and thus, we ensure that the products are sternly packed and delivered on time.
Owing to our immense expertise, we are now engaged in exporting of Anti Rabies Vaccine. Anti Rabies Vaccine is used to treat the rabies disease which is caused by a viral infection usually spread because of the bite from an infected animal like dogs, bats, foxes, etc. Anti Rabies Vaccine that we provide is prepared from accurate chemical composition and known for providing effective results with minor side-effects. We make available Anti Rabies Vaccine in tamper-proof packaging.
Composition per Single Dose :
We take immense pleasure in introducing ourselves as one of the leading companies engaged in exporting of Oral Polio Vaccine. Oral Polio Vaccine is a mixture of live attenuated poliovirus strains of three stereotypes, selected by their ability to mimic the immune response following infection with wild polioviruses. Oral Polio Vaccine produces antibodies in the blood of all three types of poliovirus and in the event of infection it protects against polio paralysis by preventing the spread of poliovirus to the nervous system. Oral Polio Vaccine that we provide does not have any side effects.
Menomune®–A/C/Y/W-135, Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined, for subcutaneous use, is a freeze-dried preparation of the group-specific polysaccharide antigens from Neisseria meningitidis, Group A, Group C, Group Y and Group W-135. N meningitidis are cultivated with Mueller Hinton agar 1 and Watson Scherp 2 media. The purified polysaccharide is extracted from the Neisseria meningitidis cells and separated from the media by procedures which include centrifugation, detergent precipitation, alcohol precipitation, solvent or organic extraction and diafiltration. No preservative is added during manufacture.
The 0.78 mL vial of diluent contains sterile, preservative-free, pyrogen-free distilled water and is used for reconstitution of product supplied in 1 ml vials. The 6 mL vial of diluent contains sterile, pyrogen-free distilled water to which thimerosal (mercury derivative) 1:10, 000 is added as a preservative. The 6 mL vial is for reconstitution of product supplied in 10 mL vials. After reconstitution with diluent as indicated on the label, the 0.5 ml dose is formulated to contain 50 μg of “isolated product” from each of Groups A, C, Yand W-135 in an isotonic sodium chloride solution.Each dose of vaccine is also formulated to contain 2.5 mg to 5 mg of lactose added as a stabilizer. 3 The vaccine when econstituted is a clear colorless liquid. Potency is evaluated by measuring the molecular size of each polysaccharide component using a column chromatography method as standardized by the US Food and Drug Administration (FDA) and the World Health Organization (WHO) 4 for Meningococcal Polysaccharide Vaccine. This Vaccine Conforms To The World Health Organization (Who) Requirements.
CERVARIX [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant] is a non-infectious recombinant, AS04-adjuvanted vaccine that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. The L1 proteins are produced in separate bioreactors using the recombinant Baculovirus expression vector system in a serum-free culture media composed of chemically-defined lipids, vitamins, amino acids, and mineral salts. Following replication of the L1 encoding recombinant Baculovirus in Trichoplusia ni insect cells, the L1 protein accumulates in the cytoplasm of the cells. The L1 proteins are released by cell disruption and purified by a series of chromatographic and filtration methods. Assembly of the L1 proteins into virus-like particles (VLPs) occurs at the end of the purification process. The purified, non-infectious VLPs are then adsorbed on to aluminum (as hydroxide salt). The adjuvant system, AS04, is composed of 3-0-desacyl-4'-monophosphoryl lipid A (MPL) adsorbed on to aluminum (as hydroxide salt).
CERVARIX is prepared by combining the adsorbed VLPs of each HPV type together with the AS04 adjuvant system in sodium chloride, sodium dihydrogen phosphate dihydrate, and Water for Injection.
CERVARIX is a sterile suspension for intramuscular injection. Each 0.5-mL dose is formulated to contain 20 mcg of HPV type 16 L1 protein, 20 mcg of HPV type 18 L1 protein, 50 mcg of the 3-0-desacyl-4'-monophosphoryl lipid A (MPL), and 0.5 mg of aluminum hydroxide. Each dose also contains 4.4 mg of sodium chloride and 0.624 mg of sodium dihydrogen phosphate dihydrate. Each dose may also contain residual amounts of insect cell and viral protein ( < 40 ng) and bacterial cell protein ( < 150 ng) from the manufacturing process. CERVARIX does not contain a preservative.
The tip caps may contain natural rubber latex; the plungers are not made with natural rubber latex.
EUFLEXXA6 is a viscoelastic, sterile solution of highly purified, high molecular weight (2.4-3.6 million daltons) hyaluronan (also known as sodium hyaluronate) in phosphate-buffered saline. EUFLEXXA! is a very highly purified product extracted from bacterial cells. It is a polysaccharide consisting of a repeating disaccharide of N-acetylglucosamine and sodium glucuronate, linked by alternating 0 4 1, 3 and P-1, 4 glycosidic bonds.
Being a highly acclaimed name in the industry engaged in Exporting of quality pharmaceutical products, we offer our clients with TD Vaccine. TD Vaccine is essentially the short form of Tetanus and Diphtheria vaccine and it is used for preventing people from fatal tetanus and diphtheria diseases. TD Vaccine that we export is prepared using superior quality chemicals in accurate composition owing to which it is highly recommended by renowned physicians. Our TD Vaccine is absolutely safe with no side-effects. Mostly used for adults, TD Vaccine is manufactured to protect the user from fatal diseases. Also, we have made available TD Vaccines to the clients at market leading prices.
ActHIB ®, Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), produced by Sanofi Pasteur SA, is a sterile, lyophilized powder which is reconstituted with either saline diluent (0.4% Sodium Chloride) or Tripedia®, Sanofi Pasteur Inc. Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP) (when reconstituted known as TriHIBit®) for intramuscular administration only. The vaccine consists of the Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate, PRP), a high molecular weight polymer prepared from the Haemophilus influenzae type b (Hib) strain 1482 grown in a semi-synthetic medium, covalently bound to tetanus toxoid.1 The lyophilized ActHIB vaccine powder and saline diluent contain no preservative. The tetanus toxoid is prepared by extraction, ammonium sulfate purification, and formalin inactivation of the toxin from cultures of Clostridium tetani (Harvard strain) grown in a modified Mueller and Miller medium.2 The culture medium contains milk derived raw materials (casein derivatives). Further manufacturing process steps reduce residual formaldehyde to levels below 0.5 micrograms (mcg) per dose by calculation. The toxoid is filter sterilized prior to the conjugation process. Potency of ActHIB vaccine is specified on each lot by limits on the content of PRP polysaccharide and protein in each dose and the proportion of polysaccharide and protein in the vaccine which is characterized as high molecular weight conjugate.
When ActHIB is reconstituted with saline diluent (0.4% Sodium Chloride), each 0.5 mL dose is formulated to contain 10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, and 8.5% of sucrose.
When ActHIB is reconstituted with Tripedia vaccine to formulate TriHIBit vaccine, each 0.5 mL dose contains10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, 8.5% of sucrose, 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid, and 46.8 mcg of pertussis antigens. Tripedia vaccine (vial presentation 0.6 mL) is formulated without preservatives but contains a trace amount of thimerosal [(mercury derivative), ( ≤ 0.3 mcg mercury/dose)] from the manufacturing process. (Refer to product insert for Tripedia vaccine.)
Mencevax ACWY is a lyophilized preparation of purified polysaccharides f rom Neisseria meningitidis (meningococcus) of groups A, C, W - 135 and Y. It is presented as a white pellet in a glass vial together with a separate vial of clear, colourless, sterile saline solvent. When reconstituted with the solvent supplied the vaccine is ready for subcutaneous injection. Each 0.5 mL dose of reconstituted vaccine contains 50 micrograms of each of the polysaccharide of groups A, C, W - 135 , and Y. Other ingredients The reconstituted vaccine also contains 12.6 mg of sucrose, 4.5 mg of sodium chloride, 0.1mg of trometamol and water for injections to 0.5ml.
We are the leading Exporter of DPT Vaccine. DPT Vaccine is a combination vaccine used against three most infectious diseases in humans, namely tetanus, diphtheria and pertussis. DPT Vaccine is enriched with diphtheria and tetanus toxoids which is effective in destroying the cells of organism called pertussis. DPT Vaccine offered by us is widely demanded owing to various attributes which include Longer Shelf Life, Accurate chemical composition, high effectiveness and least side effects.
HAVpur - Pharmacology- Provides active immunization against hepatitis A. Indication is Active immunization of patients 12 mo of age and older against disease caused by hepatitis A virus.
VAQTA is indicated for active pre-exposure prophylaxis against disease caused by hepatitis A virus in persons 2 years of age and older. Primary immunization should be given at least 2 weeks prior to expected exposure to HAV. Individuals who are or will be at increased risk of infection by HAV include :Travelers :
Military Personnel :
Certain Ethnic And Geographic Populations That Experience Cyclic Hepatitis A Epidemics Such As :
Others :
Although the epidemiology of hepatitis A does not permit the identification of other specific populations at high risk of disease, outbreaks of hepatitis A or exposure to hepatitis A virus have been described in a variety of populations in which VAQTA may be useful :
People Exposed To Hepatitis A - For those requiring both immediate and long-term protection, VAQTA may be administered concomitantly with IG. RevaccinationSee, .
Use With Other Vaccines :VAQTA may be given concomitantly at separate injection sites with typhoid and yellow fever vaccines. The GMTs for hepatitis A when VAQTA, typhoid and yellow fever vaccines were administered concomitantly were reduced when compared to VAQTA alone. Following receipt of the booster dose of VAQTA, the GMTs for hepatitis A in these two groups were observed to be comparable. (See, and, .)
The Advisory Committee on Immunization Practices has stated that limited data from studies conducted among adults indicate that simultaneous administration of hepatitis A vaccine with diphtheria, poliovirus (oral and inactivated), tetanus, oral typhoid, cholera, Japanese encephalitis, rabies, or yellow fever vaccine does not decrease the immune response to either vaccine or increase the frequency of reported adverse events. Studies indicate that hepatitis B vaccine can be administered with VAQTA without affecting immunogenicity or increasing the frequency of adverse events.
Use With Immune Globulin :
With the assistance of sophisticated packaging system and skilled personnel, we are able to provide damage-free products to the clients as we ensure complete safety during packaging. We are aware about the insecurities involved while making online transactions, thus, we strictly offer online and offline payment modes that are handled by the professionals only.
Pemetrexed Injections are used in chemotherapy (anti-cancer) medication for treating malignant pleural mesothelioma which is a cancer type that affects inside lining of chest cavity. Further, Pemetrexed alos finds usage in treating non-small cell lung cancer and comes from class of medication called antifolate antineoplastic agents. Available in form of a solution (liquid) that is injected into vein, the medicine works by blocking action of certain substance in body that can help in the further growth of cancer cells.
Natalizumab Injection is applicable in slowing the process of worsening of disability in people that are facing relapsing forms of multiple sclerosis where nerves do not function properly. Due to which people experience conditions like loss of muscle coordination, problems with vision & speech, weakness, numbness and bladder control. The medicine works by stopping certain cells of immune system from reaching brain as well as spinal cord/digestive tract that cause damage. Other than this, Natalizumab is also used for treating and preventing arising of symptoms in people having Crohn's disease where body attacks lining of digestive tract which cause diarrhea, pain, weight loss and fever. Further, Natalizumab is also used by people on whom other medications have not proven effective.
Oxaliplatin Injection is available in vitals of 100mg/20ml, 50mg/10ml and is used with other medications for treating advanced colon/rectal cancer (a type of cancer beginning in large intestine). Further, Oxaliplatin also finds usage with other medications for preventing colon cancer from spreading in people who have undergone surgery for removal of tumor. Coming from the class of medication called platinum-containing antineoplastic agents, Oxaliplatin works by killing cancer cells.
Indication : Oxitan is used in the treatment of metastatic colon or rectal cancer. Oxitan is also may be used for the treatment of late stage ovarian cancer.
Available as : Note - Oxitan is a prescription drug and should be used under proper medical guidance and advice.
Dosage : 100mg/20ml, 50mg/10ml
Bortezomib Injection acts as a cancer chemotherapy drug and finds usage for treating certain types of tumors like multiple myeloma by blocking certain proteins that support slowing the growth as well as spread of cancer. As an antineoplastic agent that is available only for intravenous injection (IV) use, each single dose vial contain 3.5 mg of bortezomib as sterile lyophilized powder with inactive ingredient comprising 35 mg mannitol, USP. As modified dipeptidyl boronic acid, it is provided as mannitol boronic ester that in reconstituted form comprises mannitol ester in equilibrium with hydrolysis product comprising monomeric boronic acid.
Infliximab Injection finds usage in relieving symptoms of certain autoimmune disorders where immune system attacks healthy parts of body which causes conditions like pain, swelling and damage. From the medication class tumor necrosis factor-alpha (TNF-alpha) inhibitors, it works by blocking action of TNF-alpha, a substance present in body that causes inflammation. This includes rheumatoid arthritis (condition where body attacks its own joints that cause pain, swelling and loss of function), Crohn's disease (where body attacks lining of digestive tract that causes pain, diarrhea, weight loss and fever) and ulcerative colitis (condition that results in swelling & sores in lining of large intestine) that occurs in adults and children of 6 years of age or older. Other than this, the injection is also used for treating cases of ankylosing spondylitis, psoriasis and psoriatic arthritis.
Herclon Trastuzumab Injection has active ingredient as Trastuzumab (Herceptin) which is a monoclonal antibody which interferes with HER2neu receptor. The main use of the injection is to treat certain breast cancers where Trastuzumab functioning as an antibody binds selectively to HER2 protein and prevents epidermal growth factor from binding, thus inhibiting effects of HER2 over-expression. Biding to HER2 proteins of cancerous cells, HER2 protein no longer cause cells in breast to uncontrollably reproduce, thus improving prognosis of women with this type of cancer.
ENGERIX-B [Hepatitis B Vaccine (Recombinant)] is a sterile suspension of noninfectious hepatitis B virus surface antigen (HBsAg) for intramuscular administration. It contains purified surface antigen of the virus obtained by culturing genetically engineered Saccharomyces cerevisiae cells, which carry the surface antigen gene of the hepatitis B virus. The HBsAg expressed in the cells is purified by several physicochemical steps and formulated as a suspension of the antigen adsorbed on aluminum hydroxide. The procedures used to manufacture ENGERIX-B result in a product that contains no more than 5% yeast protein.
Each 0.5-mL pediatric/adolescent dose contains 10 mcg of HBsAg adsorbed on 0.25 mg aluminum as aluminum hydroxide. Each 1-mL adult dose contains 20 mcg of HBsAg adsorbed on 0.5 mg aluminum as aluminum hydroxide.
ENGERIX-B contains the following excipients: Sodium chloride (9 mg/mL) and phosphate buffers (disodium phosphate dihydrate, 0.98 mg/mL; sodium dihydrogen phosphate dihydrate, 0.71 mg/mL).
ENGERIX-B is available in vials and prefilled syringes. The tip caps of the prefilled syringes may contain natural rubber latex; the plungers are not made with natural rubber latex. The vial stoppers are not made with natural rubber latex. ENGERIX-B is formulated without preservatives.
HAVRIX (Hepatitis A Vaccine) is a sterile suspension of inactivated virus for intramuscul ar administration. The virus (strain HM1 75) is propagated in MRC - 5 human diploid cells. After removal of the cell culture medium, the cells are lysed to form a suspension. This suspension is purified through ultrafiltration and gel permeation chromatography procedures.
Treatment of this lysate with formalin ensures viral inactivation. Viral antigen activity is referenced to a standard using an enzyme linke d immunosorbent assay (ELISA), and is therefore expressed in terms of ELISA Units (EL.U.). Each 1 - mL adult dose of vaccine contains 1440EL.U. of viral antigen, adsorbed on 0.5 mg of aluminum as aluminum hydroxide.
We are capable of handling both automated inbound and outbound consignments, we have excellent warehousing solutions available. We keep the extensive array of products sorted to make sure that the delivery commences thoroughly. Reckoned for the offering outstanding array of products, we are headquartered in Mumbai(India).
We hold expertise in providing a wide range of Wepox 4000 IU Injection (Rhu-erythropoietin). These are prepared in hygienic environment and with proper measure in formulating them. Our entire product range is treasured among them for its long shelf life and effective results.
Bevacizumab Injection is used in chemotherapy for treating cancer of large intestine or rectum which has gained access to other parts of the body. Further, Bevacizumab also finds its use in chemotherapy for treating certain types of lung cancer, glioblastoma (a type of cancerous brain tumor) as well as in combination with other medication in treating renal cell cancer which is a type of cancer which starts from kidney and has spread to other body parts. From the class of medication antiangiogenic agents it works by stopping formation of blood vessels which brings oxygen as well as nutrients to tumors and thus slowing growth and spread of tumors.
Erythropoietin (EPO) is a glycoprotein hormone produced primarily by the kidney in response to hypoxia and is the key regulator of red blood cell (RBC) production. EPO is involved in all phases of erythroid development, and has its principal effect at the level of erythroid precursors. After EPO binds to its cell surface receptor, it activates signal transduction pathways that interfere with apoptosis and stimulates erythoid cell proliferation.
Erythropoietin stimulates erythropoiesis in anaemic patients with chronic renal failure in whom the endogenous production of erythropoietin is impaired. Because of the length of time required for erythropoiesis – several days for erythroid progenitors to mature and be released into the circulation – a clinically significant increase in haemoglobin is usually not observed in less than two weeks and may require up to ten weeks in some patients. Erythropoiesis-stimulating agents ESAs are growth factors that primarily stimulate red cell production. Erythropoietin receptors may be expressed on the surface of a variety of tumour cells (see PRECAUTIONS – Use in Cancer Patients).
We are one of the leading Exporters of MMR Vaccine that acts as an immunization vaccine against life-threatening diseases like mumps, measles and rubella. Our MMR Vaccine is provided to children around one year and another dose of it is administered at the age of 4-5 years. We provide MMR Vaccine of well-known multinational companies like Merc &Co., GlaxoSmithKline Biologicals, and Sanofi Pasteur with the brand names of M-M-R II, Priorix, and Trimovax respectively. Long-term effects and efficacy are subject to continuing study.
We are a prominent name in the industry engaged in exporting of Okavax Vaccine. Chicken Pox Vaccine is used for the treatment of the very common disease, i.e., Okavax Vaccine. Okavax Vaccine that we export is highly recommended for children as they have the most favorable chances to catch the disease. Our Chicken Pox Vaccine is prepared using the finest quality chemicals and is free from any sort of serious side-effects.
Okavax Vaccine Is Recommended For :
Haemophilus B is a type of influenza (flu) caused by bacteria. Haemophilus B bacteria can cause breathing problems or meningitis, and these infections can be fatal. Haemophilus B conjugate (PRP-T) vaccine is used to prevent this disease in children, and is sometimes combined with vaccines to protect against other diseases. This vaccine is given to children between the ages of 2 months and 18 months old. The vaccine works by exposing your child to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. This vaccine will not treat an active infection that has already developed in the body, and will not protect against other types of influenza. Haemophilus B conjugate vaccine is not for use in children younger than 6 weeks. When used in combination with certain diphtheria vaccines, this vaccine may not be used in children younger than 15 months. Like any vaccine, haemophilus B conjugate vaccine may not provide protection from disease in every person.
Save up to 95% on your Hiberix prescription.
Mr. Chaitanya M. Shah (Troncomedizine Therapeutico)
Mumbai, Gamdevi, Maharashtra - 400007, India
Share us via
